Pfizer share news, announcements and annual reports

NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap

Pfizer Limited · Face value ₹10 · Listed Jul 1966 on BSE, Apr 1999 on NSE

₹3,687.80₹72.00 (1.92%)BSE ₹3,687.05

Share price at the NSE close on 30 Oct 2026. Previous close ₹3,759.80.

30 Oct: open ₹3,760.00, high ₹3,776.90, low ₹3,668.10

52-week range of traded prices to 30 Oct 2026

₹3,589.00Low, 23 Oct 2026₹5,346.00High, 30 Oct 2025

Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar

Market cap: ₹16,871 Cr327th largest listed
P/E: 22.95
P/B: 4.01
Dividend yield: 2.03%
ROE: 17.5%
ROCE: 21.0%
Debt to equity: 0.00
Volume, NSE: 17,12450.8% delivered

Pfizer board meetings

106 filed, newest first. Page 1 of 3.

Oct 2026
- 26 Oct · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2026, inter alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.
Sep 2026
- 7 Sep · Board meeting
  Please find enclosed outcome of the Board Meeting held today i.e., September 7, 2026.
Jul 2026
- 20 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2026
May 2026
- 12 May · Board meeting
  Outcome of Board Meeting held on May 12, 2026.
- 5 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2026 and dividend
Jan 2026
- 30 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2025
Nov 2025
- 3 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2025
Aug 2025
- 7 Aug · Board meeting
  This is to inform that a meeting of the Board of Directors of the Company is scheduled to beheld on Wednesday, August 13, 2025 inter alia, to consider, approve and take on record theUnaudited Financial Results of the Company for the quarter ended June 30, 2025.
May 2025
- 13 May · Board meeting
  This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 19, 2025 inter alia, to consider, approve and take on record the Audited Financial Results of the Company for the quarter and Financial Year ended March 31, 2025 and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2025.
Feb 2025
- 21 Feb · Board meeting
  We hereby inform that, the Board ofDirectors of the Company at their Meeting held today, that commenced on February 20, 2025at 11.00 a.m. and concluded on February 21, 2025 at 1.45 p.m have approved a proposal today,to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited( Mylan ) for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane.
Jan 2025
- 31 Jan · Board meeting
  Board meeting held on January 31, 2025.
- 24 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2024
Oct 2024
- 28 Oct · Board meeting
  We submit herewith the UnauditedFinancial Results for the quarter and half year ended September 30, 2024, which were approvedby the Board of Directors of the Company at their Meeting held today, that commenced at3.00 p.m. and concluded at 5.45 p.m.Also please find enclosed the Limited Review Report issued by the Statutory Auditors namely,B. S. R. & Co., LLP, in respect of the said Unaudited Financial Results.
- 21 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2024
Jul 2024
- 29 Jul · Board meeting
  We hereby inform you that upon recommendation of theNomination and Remuneration Committee, the Board of Directors of the Company at theirMeeting held today i.e., July 29, 2024 approved the following:1. Appointment of Mr. Lakshmanan Krishnakumar (DIN: 00423616) as an Independent Director(Additional Director) for a period of 5 years with effect from July 29, 2024.2. Appointment of Ms. Sonia Singh (DIN: 07108778) as an Independent Director(Additional Director) for a period of 5 years with effect from July 29, 2024.3. Appointment of Mr. Pradip Shah (DIN: 00066242) as a Non-Executive Non-IndependentDirector (Additional Director) with effect from November 10, 2024 liable to retire by rotation.The abovementioned appointments of Mr. Lakshmanan Krishnakumar and Ms. Sonia Singh asIndependent Directors and the appointment of Mr. Pradip Shah as a Non-Executive Non-Independent Director, will be subject to the approval of the shareholders at the ensuing AnnualGeneral Meeting of the Company.
- 22 Jul · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company is scheduledto be held on Monday, July 29, 2024, inter alia, to consider and take on record theUnaudited Financial Results of the Company for the quarter ended June 30, 2024.Pursuant to the Pfizer Limited Code of Internal Procedures and Conduct to Regulate,Monitor and Report Trading by Insiders , the Trading Window of the Company was closedfrom June 30, 2024, till 48 hours after the results are made public on July 29, 2024.
May 2024
- 6 May · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 17, 2024, inter alia, to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2024 and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2024.
Feb 2024
- 9 Feb · Board meeting
  Board meeting held on February 09, 2024.
- 9 Feb · Board meeting
  Board meeting held on February 09, 2024.
Jan 2024
- 31 Jan · Board meeting
  Meeting on 9 Feb 2024: “PFIZER LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended Decembe”
Oct 2023
- 28 Oct · Board meeting
  Appointment of Mr. P. Rengan as Executive Director Plant Operations.Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today appointed Mr. P. Rengan (DIN: 10362899) as an Additional Director of the Company, designated as Executive Director Plant Operations, for a period of 5 years with effect from October 28, 2023. The appointment of Mr. Rengan will be subject to the approval of shareholders through Postal Ballot.Request you to please take the above on record.
- 28 Oct · Board meeting
  We submit herewith the unaudited financial results for the quarter andhalf year ended September 30, 2023, which were approved by the Board of Directors of theCompany at its Meeting held today, that commenced at 12:30 p.m. and concluded at3.15 p.m. Also please find enclosed the Limited Review Report by our Statutory Auditors,M/s. B. S. R. & Co., LLP, in respect of the above results.We request you to kindly take the same on record.
- 18 Oct · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, October 28, 2023, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.Pursuant to the Pfizer Limited Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders , the Trading Window of the Company was closed from Saturday, September 30, 2023, till 48 hours after the results are made public on October 28, 2023.Request you to please take the above on record.
Aug 2023
- 4 Aug · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, August 11, 2023, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2023.Pursuant to the Pfizer Limited Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders , the Trading Window of the Company was closed from Friday, June 30, 2023 (close of business), till 48 hours after the results are made public on August 11, 2023.We request you to kindly take the same on record.
May 2023
- 5 May · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 15, 2023, inter alia, to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2023 and to consider recommendation of final dividend, if any, for the Financial Year ended March 31, 2023.Pursuant to the Pfizer Limited Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders , the Trading Window of the Company was closed from Friday, March 31, 2023 (close of business), till 48 hours after the results are made public on May 15, 2023.We request you to kindly take the same on record.
Feb 2023
- 1 Feb · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 9, 2023, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2022.Pursuant to the Pfizer Limited Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders , the Trading Window of the Company was closed from Saturday, December 31, 2022, till 48 hours after the results are made public on February 9, 2023.We request you to kindly take the above on record.
Nov 2022
- 3 Nov · Board meeting
  This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 11, 2022, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022.Pursuant to the Pfizer Limited Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders, the Trading Window of the Company was closed from Friday, September 30, 2022 (close of business) till 48 hours after the results are made public on November 11, 2022.We request you to kindly take the same on record.
Sep 2022
- 6 Sep · Board meeting
  Outcome of the Board Meeting Declaration of Interim (Special) Dividend for the Financial Year ending March 31, 2023, and Intimation of Record Date.
- 1 Sep · Board meeting
  Board Meeting to consider declaration of Interim Dividend for the Financial Year ending March 31, 2023.
Aug 2022
- 5 Aug · Board meeting
  We submit herewith the unaudited financial results for the quarter ended June 30, 2022, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 12:00 noon and concluded at 2:45 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results.
Jul 2022
- 27 Jul · Board meeting
  Board Meeting for consideration and to take on record the Unaudited Financial Results for the quarter ended June 30, 2022.
May 2022
- 10 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 20, 2022, inter alia, to consider and take on record the Audited Financial Results of the Company for the Financial Year ended March 31, 2022, and to consider recommendation of dividend, if any, for the Financial Year ended March 31, 2022.Pursuant to the "Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders", the Trading Window of the Company was closed from Thursday, March 31, 2022 (close of business) till 48 hours after the results are made public on May 20, 2022.We request you to kindly take the same on record.
Feb 2022
- 3 Feb · Board meeting
  Board meeting held on February 03, 2022.
Jan 2022
- 24 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2021
Oct 2021
- 25 Oct · Board meeting
  Board Meeting for consideration and to take on record the Unaudited Financial Results for the quarter and half year ended September 30, 2021.
Jul 2021
- 16 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021
May 2021
- 14 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2021 and dividend
Jan 2021
- 27 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2020
Nov 2020
- 2 Nov · Board meeting
  Board meeting held on November 02, 2020.
Oct 2020
- 22 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2020
Jul 2020
- 17 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2020
Jun 2020
- 5 Jun · Board meeting
  To consider and approve the financial results for the period ended March 31, 2020 and dividend
Apr 2020
- 22 Apr · Board meeting
  To consider Interim dividend for the Financial Year ended March 31, 2020
Feb 2020
- 3 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2019
Oct 2019
- 15 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2019
Jul 2019
- 29 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2019
May 2019
- 17 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2019 and dividend
Jan 2019
- 14 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2018
Nov 2018
- 2 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2018
Jul 2018
- 25 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2018

Pfizer board meetings

Oct 2026

Sep 2026

Jul 2026

May 2026

Jan 2026

Nov 2025

Aug 2025

May 2025

Feb 2025

Jan 2025

Oct 2024

Jul 2024

May 2024

Feb 2024

Jan 2024

Oct 2023

Aug 2023

May 2023

Feb 2023

Nov 2022

Sep 2022

Aug 2022

Jul 2022

May 2022

Feb 2022

Jan 2022

Oct 2021

Jul 2021

May 2021

Jan 2021

Nov 2020

Oct 2020

Jul 2020

Jun 2020

Apr 2020

Feb 2020

Oct 2019

Jul 2019

May 2019

Jan 2019

Nov 2018

Jul 2018